Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner Agios Pharmaceuticals, Inc. (Nasdaq: ...
About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
Recap and analysis of Mount Sinai Biodesign's 2025 NY Brain-computer interface symposium, featuring Synchron, Precision, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback